Stocks · Healthcare · Biotechnology
Lineage Cell Therapeutics, Inc. LCTX
$0.93 +2.89% Close, Oct 2, 2026 · AMEX · Market cap $231.9M
Weak trend
Next earnings report: Nov 5, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to -205.2% from -322.8% a year earlier.
- The diluted share count rose 14.5% in a year.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 33%
- Revenue growth, 3-year CAGRBottom 23%
- Revenue growth accelerationBottom 8%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 48%
- Gross marginTop 11%
- Operating marginBottom 24%
- Accruals (lower is better)Top 42%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 39%
- Free-cash-flow yieldBottom 37%
- EBITDA / enterprise valueBottom 28%
- Sales / enterprise valueBottom 24%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 13%
- 6-month returnBottom 8%
- 1-year return vs S&P 500Bottom 13%
- Distance from 52-week highBottom 22%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 5%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyTop 10%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Top 41%
- Maximum drawdown, 3 yearsBottom 44%
- Beta vs S&P 500 (lower is better)Bottom 45%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 54.6% | 19.9% | ↓ |
| Gross margin | 97.6% | 96.6% | ↓ |
| Operating margin | -322.8% | -205.2% | ↑ |
| FCF margin | -212.1% | -183.0% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 19.9% | 54.6% | ↓ | Top 33% |
| Gross margin | 96.6% | 97.6% | ↓ | Top 11% |
| Operating margin | -205.2% | -322.8% | ↑ | Bottom 24% |
| Net margin | -246.6% | -374.8% | ↑ | — |
| Free-cash-flow margin | -183.0% | -212.1% | ↑ | — |
| Return on invested capital | -23.3% | — | Bottom 48% | |
| Revenue growth, 3-year CAGR | -0.3% | — | Bottom 23% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -7.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 38.8%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- +188.7 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -14.04%
- Shareholder yield
- -14.04%
- Share count change, 1 year
- +14.5%
- Share count change, 3-year CAGR
- +15.3%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- -100.0%
- Average 2-day reaction, last 8
- -1.7%
- Positive 20 days after report
- 2 of 8
Analysts
- Analysts with a rating
- 5
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | -5.9% | -0.9% | -3.5% | -2.6% | — |
| May 12, 2026 | -50.0% | +1.5% | -5.3% | -6.9% | -13.7% |
| Mar 5, 2026 | +109.2% | -5.6% | -13.8% | -18.5% | -31.8% |
| Nov 6, 2025 | -550.0% | -4.9% | +6.0% | -4.4% | -3.3% |
| Aug 12, 2025 | +50.0% | +0.0% | +26.7% | +25.7% | +78.2% |
| May 13, 2025 | +0.0% | -1.9% | +3.8% | +55.5% | +98.5% |
| Mar 10, 2025 | +75.0% | +1.1% | -1.0% | -17.7% | +29.1% |
| Nov 14, 2024 | -53.5% | -3.1% | -29.7% | -43.0% | -29.8% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.03 | -$0.03 | -5.9% | $1.1M |
| May 12, 2026 | -$0.03 | -$0.02 | -50.0% | $1.7M |
| Mar 5, 2026 | $0.00 | -$0.04 | +109.2% | $6.6M |
| Nov 6, 2025 | -$0.13 | -$0.02 | -550.0% | $3.7M |
| Aug 12, 2025 | -$0.01 | -$0.02 | +50.0% | $2.8M |
| May 13, 2025 | -$0.02 | -$0.02 | +0.0% | $1.5M |
| Mar 10, 2025 | -$0.01 | -$0.04 | +75.0% | $2.9M |
| Nov 14, 2024 | -$0.02 | -$0.01 | -53.5% | $3.8M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 15.05× | — | — | Bottom 24% |
| Free-cash-flow yield | -10.32% | — | — | Bottom 37% |
| Earnings yield | -14.63% | — | — | Bottom 39% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -8.0%
- 200-day average slope (20 days)
- -4.8%
- Distance from 50-day average
- -12.3%
- Distance from 200-day average
- -33.5%
- RSI (14)
- 39.1
- Relative volume
- 0.79×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 50.5%
- Volatility vs own 5-year history
- 13th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.20
- Correlation with S&P 500
- 0.23
- Current drawdown from 1-year high
- -52.5%
- Maximum drawdown, 3 years
- -73.9%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Feb 17, 2021 | Apr 8, 2025 | -87.5% | 1040 days | Not yet recovered |
| Jan 20, 2021 | Jan 29, 2021 | -26.3% | 7 days | 10 days (Feb 12, 2021) |
| Oct 14, 2020 | Oct 30, 2020 | -19.7% | 12 days | 8 days (Nov 11, 2020) |
| Nov 12, 2020 | Nov 24, 2020 | -17.9% | 8 days | 7 days (Dec 4, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $231.9M
- EPS, diluted (TTM)
- -$0.14
- Revenue (TTM)
- $13.1M
- 52-week range
- $0.88 – $2.09
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $3.9M | $14.7M | $8.9M | $9.5M | $14.6M |
| Gross profit | $2.5M | $14.0M | $8.3M | $9.2M | $13.7M |
| Operating income | -$49.2M | -$22.5M | -$24.7M | -$21.5M | -$21.8M |
| Net income | -$43.0M | -$26.3M | -$21.5M | -$18.6M | -$63.5M |
| EPS (diluted) | -$0.26 | -$0.15 | -$0.12 | -$0.09 | -$0.28 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.8M | $2.9M | $1.5M | $2.8M | $3.7M | $6.6M | $1.7M | $1.1M |
| Net income | -$3.0M | -$3.3M | -$4.1M | -$30.5M | -$29.8M | $851,000 | -$4.8M | $1.5M |
| EPS (diluted) | -$0.02 | -$0.02 | -$0.02 | -$0.13 | -$0.13 | $0.00 | -$0.02 | $0.01 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$23.6M | $1.1M | -$28.6M | -$23.1M | -$18.9M |
| Capital expenditure | -$354,000 | -$413,000 | -$674,000 | -$565,000 | -$522,000 |
| Free cash flow | -$23.9M | $646,000 | -$29.2M | -$23.7M | -$19.4M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $30.8M | $131,000 | $6.6M | $35.9M | $27.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $50.8M
- Total assets
- $106.2M
- Total liabilities
- $46.4M
- Total debt
- $2.3M
- Net debt
- -$35.1M
- Shareholders’ equity
- $60.9M
As of Jun 30, 2026 (filed Aug 6, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Dec 15, 2003 | $0.08 | — |
Short interest
- Shares sold short
- 29,468,651
- Days to cover
- 26.64
- Change vs previous report
- +1.7%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Oct 31, 1997
- 3-for-1